Can atorvastatin improve the response to sildenafil in men with erectile dysfunction not initially responsive to sildenafil? Hypothesis and pilot trial results
Background: Erectile dysfunction (ED) may be one manifestation of a generalized vascular disorder characterized by endothelial dysfunction. Statin drugs may improve endothelial function, even before altering the lipid profile.
Objective: We sought to determine whether the addition of a statin with sildenafil would improve ED in men who initially responded poorly to sildenafil.
Methods: Men with moderate-to-severe ED despite an adequate sildenafil trial were enrolled in this randomized, double-blind, placebo-controlled pilot study. ED was defined using a validated self-administered questionnaire as a score of
Results: Twelve men (mean age 58 +/- 13 years) with a mean domain score of 8.2 +/- 6.9 and a mean duration of ED of 3.7 years were enrolled in the study. Treatment with atorvastatin decreased mean low-density lipoprotein cholesterol by 43% and resulted in an improvement with sildenafil in domain score of 7.8 (P = 0.036); an effect was apparent by 6 weeks. The increase in domain score in placebo patients was not statistically significant.
Conclusions: Treatment with atorvastatin improved sexual function and the response to oral sildenafil in men who did not initially respond to treatment with sildenafil. The results of this pilot study support the hypothesis that vascular endothelial dysfunction contributes to ED in sildenafil nonresponders and deserves further testing in a large clinical trial.
Similar articles
Dadkhah F, Safarinejad MR, Asgari MA, Hosseini SY, Lashay A, Amini E. Dadkhah F, et al. Int J Impot Res. 2010 Jan-Feb;22(1):51-60. doi: 10.1038/ijir.2009.48. Epub 2009 Oct 29. Int J Impot Res. 2010. PMID: 19865092 Clinical Trial.
Gokkaya SC, Ozden C, Levent Ozdal O, Hakan Koyuncu H, Guzel O, Memis A. Gokkaya SC, et al. Scand J Urol Nephrol. 2008;42(5):437-40. doi: 10.1080/00365590801950279. Scand J Urol Nephrol. 2008. PMID: 18609275
Bank AJ, Kelly AS, Kaiser DR, Crawford WW, Waxman B, Schow DA, Billups KL. Bank AJ, et al. Vasc Med. 2006 Nov;11(4):251-7. doi: 10.1177/1358863×06072221. Vasc Med. 2006. PMID: 17390549 Clinical Trial.
Montorsi F, Padma-Nathan H, Glina S. Montorsi F, et al. Urology. 2006 Sep;68(3 Suppl):26-37. doi: 10.1016/j.urology.2006.06.027. Urology. 2006. PMID: 17011373 Review.
King R, Juenemann KP, Levinson IP, Stecher VJ, Creanga DL. King R, et al. Int J Impot Res. 2007 Jul-Aug;19(4):398-406. doi: 10.1038/sj.ijir.3901549. Epub 2007 Mar 15. Int J Impot Res. 2007. PMID: 17361232 Review.
Cited by
Zhang K, Zhou J, Li A, Chen M. Zhang K, et al. Front Med (Lausanne). 2023 Jul 12;10:1162153. doi: 10.3389/fmed.2023.1162153. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37502356 Free PMC article.
Esmail M, Kandeil M, El-Zanaty AM, Abdel-Gabbar M. Esmail M, et al. F1000Res. 2020 Nov 5;9:1300. doi: 10.12688/f1000research.25926.1. eCollection 2020. F1000Res. 2020. PMID: 33628436 Free PMC article.
Mykoniatis I, Pyrgidis N, Sokolakis I, Ouranidis A, Sountoulides P, Haidich AB, van Renterghem K, Hatzichristodoulou G, Hatzichristou D. Mykoniatis I, et al. JAMA Netw Open. 2021 Feb 1;4(2):e2036337. doi: 10.1001/jamanetworkopen.2020.36337. JAMA Netw Open. 2021. PMID: 33599772 Free PMC article.
Cai Z, Song X, Zhang J, Yang B, Li H. Cai Z, et al. Aging Dis. 2020 Oct 1;11(5):1202-1218. doi: 10.14336/AD.2019.1028. eCollection 2020 Oct. Aging Dis. 2020. PMID: 33014533 Free PMC article. Review.
Lee M, Sharifi R. Lee M, et al. Drugs Aging. 2018 Mar;35(3):175-187. doi: 10.1007/s40266-018-0528-4. Drugs Aging. 2018. PMID: 29464656 Review.
